Ole Isacson

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Neuroregeneration
Google:
"Ole Isacson"
Mean distance: 15.2 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Brekk OR, Honey JR, Lee S, et al. (2020) Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbance. Proceedings of the National Academy of Sciences of the United States of America
Brekk OR, Korecka JA, Crapart CC, et al. (2020) Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity. Acta Neuropathologica Communications. 8: 127
Thomas R, Hallett PJ, Isacson O. (2020) Experimental studies of mitochondrial and lysosomal function in in vitro and in vivo models relevant to Parkinson's disease genetic risk. International Review of Neurobiology. 154: 279-302
Korecka JA, Thomas R, Hinrich AJ, et al. (2020) Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice. Molecular Therapy. Nucleic Acids. 21: 623-635
Osborn TM, Hallett PJ, Schumacher JM, et al. (2020) Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease Patients. Frontiers in Cellular Neuroscience. 14: 58
Huebecker M, Moloney EB, van der Spoel AC, et al. (2020) Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease. Molecular Neurodegeneration. 15: 6
Huebecker M, Moloney EB, van der Spoel AC, et al. (2019) Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease. Molecular Neurodegeneration. 14: 40
Isacson O, Brekk OR, Hallett PJ. (2019) Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease. Frontiers in Neurology. 10: 1053
Menon V, Thomas R, Elgueta C, et al. (2019) Comprehensive cell surface antigen analysis identifies transferrin receptor protein-1 (CD71) as a negative selection marker for human neuronal cells. Stem Cells (Dayton, Ohio)
Hallett PJ, Engelender S, Isacson O. (2019) Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's disease. Journal of Neuroinflammation. 16: 153
See more...